| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
TriSalus Life Sciences, Inc.
13D/A
Amendment 2
TLSI · 89680M101
|
6.0% |
8/1/2025
Event 7/31/2025
|
|||
| Mats Wahlstrom | 6.0% | ||||
| Kerry R. Hicks | 4.7% | ||||
| HW Investment Partners, LLC | 2.8% | ||||
| HW Investment Partners, LLC | 2.8% | ||||
|
TriSalus Life Sciences, Inc.
13D/A
Amendment 1
TLSI · 89680M101
|
9.0% |
12/19/2024
Event 12/17/2024
|
|||
| Mats Wahlstrom | 9.0% | ||||
| Kerry R. Hicks | 7.5% | ||||
| HW Investment Partners, LLC | 4.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.